S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
S&P 500   3,244.67 (-2.79%)
DOW   28,135.44 (-2.96%)
QQQ   222.48 (-3.38%)
AAPL   299.54 (-4.32%)
FB   200.89 (-4.42%)
MSFT   172.47 (-3.43%)
GOOGL   1,424.47 (-3.98%)
AMZN   2,002.89 (-4.44%)
CGC   20.90 (-4.48%)
NVDA   277.89 (-5.50%)
BABA   205.42 (-3.38%)
MU   54.68 (-4.05%)
GE   11.91 (-2.78%)
TSLA   843.04 (-6.43%)
AMD   49.75 (-6.63%)
ACB   1.59 (-4.80%)
F   7.64 (-3.17%)
BAC   32.94 (-4.13%)
DIS   132.35 (-4.76%)
GILD   72.85 (+4.52%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 BIOFRONTERA AG/ADRKala PharmaceuticalsSol Gel TechnologiesSeres TherapeuticsEvofem Biosciences
SymbolNASDAQ:BFRANASDAQ:KALANASDAQ:SLGLNASDAQ:MCRBNASDAQ:EVFM
Price Information
Current Price$10.94$6.33$11.50$3.51$6.33
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$14.50$18.20$26.50$9.00$10.33
% Upside from Price Target32.54% upside187.52% upside130.43% upside156.41% upside63.24% upside
Trade Information
Market Cap$230.48 million$239.23 million$237.54 million$267.44 million$296.32 million
Beta0.711.951.281.790.55
Average Volume268562,153115,942184,03376,846
Sales & Book Value
Annual Revenue$24.93 million$6.07 million$130,000.00$28.27 millionN/A
Price / Sales9.8438.381,803.738.69N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.87 per share$0.86 per share$3.38 per share($1.18) per share($0.90) per share
Price / Book12.577.363.40-2.97N/A
Profitability
Net Income$-10,480,000.00$-94,350,000.00$-32,200,000.00$-98,940,000.00$-125,710,000.00
EPSN/A($2.76)($1.80)($2.43)($5.74)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E Ratio∞N/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-23.35%-1,553.29%-223.99%-194.04%N/A
Return on Equity (ROE)-34.45%-173.83%-71.98%N/A-2,868.15%
Return on Assets (ROA)-10.01%-54.37%-63.22%-57.29%-218.29%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.56%2.40%N/AN/AN/A
Current Ratio1.99%4.26%7.80%2.12%2.52%
Quick Ratio1.72%4.07%7.80%2.12%2.52%
Ownership Information
Institutional Ownership Percentage0.09%63.06%25.62%94.18%64.52%
Insider Ownership PercentageN/A30.77%N/A37.00%13.40%
Miscellaneous
Employees149130N/A14530
Shares Outstanding22.42 million36.80 million20.39 million70.01 million46.81 million
Next Earnings Date5/4/2020 (Estimated)5/14/2020 (Estimated)3/19/2020 (Estimated)3/4/2020 (Estimated)3/6/2020 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableNot Optionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel